New deal with Pitt continues the IMUC trend of gathering up all the necessary pieces to move forward with ICT-140. IND application to be filed this year. This is huge, world wide patent exclusivity to treat ovarian and pancreatic cancers. It's news like this that keep the share price moving upwards and reassures investors that they've made a good decision on IMUC.
Yes, great catalyst moving forward. http://finance.yahoo.com/news/immunocellular-therapeutics-licenses-novel-immunotherapeutic-120000952.html